Targeting necroptosis in fibrosis

Mol Biol Rep. 2023 Dec;50(12):10471-10484. doi: 10.1007/s11033-023-08857-9. Epub 2023 Nov 1.

Abstract

Necroptosis, a type of programmed cell death that resembles necrosis, is now known to depend on a different molecular mechanism from apoptosis, according to several recent studies. Many efforts have reported the possible influence of necroptosis in human disorders and concluded the crucial role in the pathophysiology of various diseases, including liver diseases, renal injuries, cancers, and others. Fibrosis is the most common end-stage pathological cascade of several chronic inflammatory disorders. In this review, we explain the impact of necroptosis and fibrosis, for which necroptosis has been demonstrated to be a contributing factor. We also go over the inhibitors of necroptosis and how they have been applied to fibrosis models. This review helps to clarify the role of necroptosis in fibrosis and will encourage clinical efforts to target this pathway of programmed cell death.

Keywords: Fibrosis; MLKL; Necroptosis; RIPK1; RIPK3.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Fibrosis
  • Humans
  • Necroptosis*
  • Protein Kinases* / metabolism
  • Receptor-Interacting Protein Serine-Threonine Kinases / metabolism

Substances

  • Protein Kinases
  • Receptor-Interacting Protein Serine-Threonine Kinases